Q2 FY2026 EarningsQ2 FY26 revenue of $9.7M missed consensus of $11.5M, while gross margin of 76.2% fell short of the 77.6% mean expectation. The company reported a GAAP net loss of $0.68M ($0.08 per share), which was wider than the $0.03 loss per share anticipated by analysts. Underperformance was driven by a 34% decline in UltraMIST system sales, despite strong 12% growth in consumables, leading to a negative operating variance across all profitability tiers.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: SANUWAVE Health(SNWV) the Revenue is 9.739 M (-3.13%);the EBIT is -280 K (-119.5%);the EPS is -0.08 (-67.07%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.01B3.13%
----
----
EBIT
-0.00B119.47%
----
----
EPS
-0.0867.07%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf